Holen Sie sich die Stockscreener-App
0.78
2.76%
-0.0221
Aptorum Group Ltd Aktie (APM) Neueste Nachrichten
Aptorum-backed DiamiR expands Alzheimer’s diagnostic efforts - Longevity.Technology
Aptorum Group Ltd (APM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Form 6K Aptorum Group Ltd For: 22 June By Investing.com - Investing.com South Africa
Press Release: Aptorum Group Announces Collaboration Between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer's Disease Biomarkers - Moomoo
Aptorum | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment) - Moomoo
Aptorum Group Ltd (APM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aptorum Group Ltd (APM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aptorum Group Ltd (APM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aptorum Group Ltd (APM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aptorum Group Ltd (APM) Institutional Confidence - TradingKey
Aptorum Group Ltd (APM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aptorum Group Ltd (APM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aptorum Group Ltd (APM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
APM News | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Aptorum Shareholders Approve Proposed Merger With DiamiR Biosciences - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Aptorum Group Limited Announces Board of Directors Appointments - marketscreener.com
Aptorum shareholders approve merger with DiamiR Biosciences By Investing.com - Investing.com South Africa
Aptorum Group Limited and DiamiR Biosciences Corp. Shareholders Approve Merger Transaction - Quiver Quantitative
Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences - Yahoo Finance
APMAptorum Group Ltd Stock Price and Quote - Finviz
Aptorum Group Limited (APM) Hovers Near Support at $0.80 After Marginal DeclinePut Spread Alert - newsline.com
APM | Aptorum Group Limited Class Insider Trading - Quiver Quantitative
APM Technical Analysis | Trend, Signals & Chart Patterns | APTORUM GROUP LTD-CLASS A (NASDAQ:APM) - ChartMill
Why Is Aptorum Group Limited (APM.PA) Stock Down Today? - Meyka
RVPH Stock Price and Chart — OTC:RVPH - TradingView
Aptorum | EFFECT: Others - Moomoo
TradingKey - TradingKey
Aptorum | S-4/A: Registration of securities issued in business combination transactions (Amendment) - Moomoo
Aptorum Group to Domesticate, Merge with DiamiR (NASDAQ: APM) - Stock Titan
Is Aptorum (APM) stock considered high volatility (Slight Gain) 2026-04-22Swing Trade - newser.com
Can Aptorum (APM) Stock Double in 2026 | Price at $0.93, Up 0.29%Continuation Pattern - Newser
XBIO PE Ratio & Valuation, Is XBIO Overvalued - Intellectia AI
APRE PE Ratio & Valuation, Is APRE Overvalued - Intellectia AI
APM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aptorum Group Soars Over 20% as Market Deciphers Regulatory Chaos and Sector Growth Signals - Bitget
DiamiR merger gives Aptorum (NASDAQ: APM) holders 30% of new Niki BioSolutions - stocktitan.net
Aptorum (NASDAQ: APM) to merge with DiamiR; domestication and share issuance - Stock Titan
Direxion Daily AMZN Bull 2X Shares (NASDAQ:AMZU) Short Interest Up 22.7% in March - Defense World
APTORUM GROUP PB Ratio: 0.29 | Possible Value Trap - GuruFocus
Going concern warning and high risk profile at Aptorum Group (NASDAQ: APM) - Stock Titan
Aptorum (NASDAQ: APM) delays DiamiR merger cutoff to June 30, 2026 - Stock Titan
If You Invested $1,000 in Aptorum Group Ltd (APM) - Stock Titan
Aptorum Group (APM) Stock Analysis Report | Financials & Insights - Benzinga Japan
[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC FilingForm 6-K - Stock Titan
Aptorum, DiamiR publish glioblastoma blood test study By Investing.com - Investing.com South Africa
Aptorum, DiamiR publish glioblastoma blood test study - Investing.com Nigeria
Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania - Bitget
Blood test study takes aim at glioblastoma, deadliest brain cancer - Stock Titan
User - The Chronicle-Journal
Aptorum Group Receives Nasdaq Compliance Notification - Intellectia AI
APM | Aptorum Group Limited Class FinancialsIncome Statement - Quiver Quantitative
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - The Chronicle-Journal
APM Should I Buy - Intellectia AI
Aptorum Group Limited (NASDAQ:APM) Short Interest Up 232.3% in February - Defense World
Aptorum Group Ltd (APM) Income Statement - TradingKey
Can Aptorum Group Limited stock outperform in a bear marketTrade Risk Summary & Target Return Focused Stock Picks - mfd.ru
APM PE Ratio & Valuation, Is APM Overvalued - Intellectia AI
Exit Recap: Is Aptorum Group Limited forming a double bottom2025 Support & Resistance & Weekly Top Stock Performers List - baoquankhu1.vn
CEO Change: Will Aptorum Group Limited stock hit new highs in YEARTrade Performance Summary & Step-by-Step Trade Execution Guides - baoquankhu1.vn
1.53%
3.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):